AUROPHARMA — Aurobindo Pharma Share News
0.000.00%
Last trade - 00:00- IN₹904.32bn
- IN₹877.78bn
- IN₹336.53bn
Brief: Biomarin To Acquire Amicus Therapeutics For $4.8 Billion
Brief: Aurobindo Pharma Says US FDA Completes Inspection Of APL Healthcare Unit 4
Brief: Aurobindo Pharma Says Completion Of US FDA Inspection At Unit-V Of Unit
GlaxoSmithKline India reports higher second-quarter profit on specialty medicine growth
Aurobindo Pharma's profit rises on steady domestic demand
Brief: Aurobindo Pharma Q2 Consol Net Profit 8.48 Billion Rupees
Brief: Aurobindo Pharma Says Small Fire Incident Occurred In Granulation Area-10 Of Unit IV Of APL Healthcare
Private equity firm Advent to sell generic drugmaker Zentiva to GTCR (updated)
Brief: Aurobindo Pharma Says US FDA Completes Inspection At Unit-XII
Health Rounds: Clopidogrel better than aspirin for preventing heart attacks and strokes
Health Rounds: Clopidogrel better than aspirin for preventing heart attacks and strokes
Curateq Biologics Receives Mhra Approval For Dazulbys
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
India's Aurobindo Pharma recoups losses after saying no binding agreement for Zentiva
India's Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5 billion, Economic Times reports (updated)
India's Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5 billion, Economic Times reports
India's Aurobindo Pharma drops on quarterly profit fall
India's Aurobindo Pharma reports profit fall as cost rise outweighs sales growth